MedPath

NEVIREX 200 (Nevirapine Tablets USP 200 mg)

Registration Number: MAL08042461AZ

Approved
Approval ID

5bc8679f5b5a1199

Registration Number

MAL08042461AZ

Registration Date

Jul 7, 2025

Regulatory Authority
NPRA
Malaysia

Product Information

Additional product specifications and packaging information as registered with NPRA Malaysia.

Product Specifications

PRODUCT SPECIFICATIONS

Official SourceNPRA Database
Available Package Types1 type
Last UpdatedJul 7, 2025

PACKAGING INFORMATION (1)

60Tablet TabletsAvailable
Package Size: 60Tablet Tablets
Status: NPRA Approved

Active Ingredients

Active pharmaceutical ingredients contained in this NPRA-approved product.

Ingredients (1)

NEVIRAPINEActive
Monograph: 奈韦拉平

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

NEVIREX 200 (Nevirapine Tablets USP 200 mg) - NPRA Drug Approval Details | MedPath - Medical Intelligence Platform